AI-driven method stabilizes mRNA vaccines at room temperature for a year
MIT researchers used an AI algorithm to identify excipient combinations that stabilize mRNA-lipid nanoparticle vaccines, allowing them to remain active at 37°C for two months or room temperature for one year without losing efficacy.